NAMS Competitors & Alternatives
Compare NewAmsterdam Pharma Company N.V. Ordinary Shares with similar stocks in the same industry
Biotechnology
NAMS
Main Stock$27.87
Tradestie Score
60
Market Cap
$3.31B
Revenue Growth
-0.8%
Analyst Upside
+86.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LGND
Ligand Pharmaceuticals Inc.
|
$286.29
|
$3.49B | 29.9 | 60 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.33
|
$3.40B | - | 37 | Compare |
|
QURE
uniQure N.V.
|
$48.37
|
$3.39B | - | 41 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$56.50
|
$3.33B | - | 32 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.65
|
$3.09B | - | 42 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$33.89
|
$3.08B | - | 54 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$60.77
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$79.81
|
$3.01B | - | 39 | Compare |
More NAMS Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry